I get a great blessing from sitting at the bedside of the sickest of the sick and making sure to see them as human beings, not just an illness.” ...

Our lab develops novel computational methods to study cellular biological systems from a global and data-driven perspective. We seek to exploit diverse, high-throughput functional and genomic data to ...

Beatriz Sawaya came to MSK from Brazil to receive a new treatment for resistant breast cancer as part of a clinical trial. The therapy has kept her cancer under control for more than five years and ...

In 2019, Michael Rosenblum received an experimental new prostate cancer treatment after the disease spread to his bones. He remains symptom-free. The treatment is now approved for more patients.

A new study leveraged data from the MSK-IMPACT tumor sequencing test to learn about the genetic complexity of cancer metastasis. When cancer spreads from a primary tumor to new sites throughout the ...

A research team is shedding new light on Bacillus Calmette-Guerin (BCG), a decades-old bladder cancer treatment, which is also given as vaccine against tuberculosis. The findings could help improve ...

MSK cellular therapist Dr. Heather Landau led a phase 1 clinical trial showing CAR T cell therapy is effective against relapsed or resistant AL amyloidosis. “I’ve seen very sick patients have an ...

A clinical trial at MSK found that music therapy for cancer-related anxiety is as effective as cognitive behavioral therapy and produces long-lasting benefits. Dr. Kevin Liou presented the results of ...

Hear how cancer patients can preserve their fertility, with expert insights and inspiring stories from survivors and new parents. While cancer treatments can be lifesaving, they can also impact the ...

A decade ago, a clinical trial in the U.K. famously showed that children who were exposed to peanuts in the early months of life had reduced risk of developing a peanut allergy compared with children ...

Since she enrolled in a clinical trial at MSK to treat her low-grade serous ovarian cancer, Ellen Coopersmith has a new outlook on life. The first drug for a rare and difficult-to-treat type of ...

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.